Trials / Completed
CompletedNCT03129568
Transcoronary Infusion of Cardiac Progenitor Cells in Pediatric Dilated Cardiomyopathy
A Prospective Phase 1 Trial of Cardiac Progenitor Cell Therapy in Children With Dilated Cardiomyopathy
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 5 (actual)
- Sponsor
- Okayama University · Academic / Other
- Sex
- All
- Age
- 17 Years
- Healthy volunteers
- Not accepted
Summary
A phase 1 prospective study to determine the procedural feasibility and safety and preliminary efficacy of intracoronary infusion of cardiosphere-derived cells (CDCs) in patients with dilated cardiomyopathy.
Detailed description
Five consecutive patients will be enrolled to a phase 1 study to verify the procedural feasibility and safety with the CDC infusion group.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | CDC infusion | Injection of CDCs (0.3 million per kg of body weight). |
Timeline
- Start date
- 2017-04-14
- Primary completion
- 2018-09-17
- Completion
- 2020-12-09
- First posted
- 2017-04-26
- Last updated
- 2021-11-26
- Results posted
- 2021-11-01
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT03129568. Inclusion in this directory is not an endorsement.